The lung cancer paradox: time for action.
作者信息
Rintoul R C, Sethi T
机构信息
Lung Inflammation Group, Centre for Inflammation Research, Medical School, University of Edinburgh, UK.
出版信息
Thorax. 2002 Oct;57 Suppl 2(Suppl 2):II57-II63.
Abstract
摘要
相似文献
1
The lung cancer paradox: time for action.肺癌悖论：是时候采取行动了。
Thorax. 2002 Oct;57 Suppl 2(Suppl 2):II57-II63.
2
Adjuvant chemotherapy for lung cancer.肺癌辅助化疗
N Engl J Med. 2004 Apr 15;350(16):1681-3; author reply 1681-3. doi: 10.1056/NEJM200404153501617.
3
Adjuvant chemotherapy for lung cancer.肺癌辅助化疗
N Engl J Med. 2004 Apr 15;350(16):1681-3; author reply 1681-3.
4
Adjuvant chemotherapy for lung cancer.
N Engl J Med. 2004 Apr 15;350(16):1681-3; author reply 1681-3.
5
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.非小细胞肺癌根治性放疗（>59 Gy）及同步化疗后的肺切除术
Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. doi: 10.1016/j.athoracsur.2004.04.085.
6
Adjuvant chemotherapy for lung cancer.
N Engl J Med. 2004 Apr 15;350(16):1681-3; author reply 1681-3.
7
Adjuvant chemotherapy for lung cancer.
N Engl J Med. 2004 Apr 15;350(16):1681-3; author reply 1681-3.
8
The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.ANITA试验为非小细胞肺癌的辅助治疗敲定了方案。
Clin Lung Cancer. 2005 May;6(6):331-2.
9
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.年龄对完全切除的非小细胞肺癌辅助顺铂化疗效果的汇总分析。
J Clin Oncol. 2008 Jul 20;26(21):3573-81. doi: 10.1200/JCO.2008.16.2727.
10
Adjuvant UFT therapy does not increase survival in people with resected stage 1 non-small cell lung cancer.
Cancer Treat Rev. 2005 Oct;31(6):487-90. doi: 10.1016/j.ctrv.2005.07.002. Epub 2005 Sep 26.
本文引用的文献
1
Screening for lung cancer with low-dose spiral computed tomography.低剂量螺旋计算机断层扫描筛查肺癌
Am J Respir Crit Care Med. 2002 Feb 15;165(4):508-13. doi: 10.1164/ajrccm.165.4.2107006.
2
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.紫杉醇、多西他赛、吉西他滨和长春瑞滨治疗非小细胞肺癌的临床疗效及成本效益：一项系统评价
Thorax. 2002 Jan;57(1):20-8. doi: 10.1136/thorax.57.1.20.
3
One-day admission for major lung resections in septuagenarians and octogenarians: a comparative study with a younger cohort.七十和八十多岁老人行主要肺切除手术的一日入院治疗：与年轻队列的比较研究
Eur J Cardiothorac Surg. 2001 Sep;20(3):449-53; discussion 453-4. doi: 10.1016/s1010-7940(01)00835-1.
4
The influence of hospital volume on survival after resection for lung cancer.医院规模对肺癌切除术后生存率的影响。
N Engl J Med. 2001 Jul 19;345(3):181-8. doi: 10.1056/NEJM200107193450306.
5
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.对不适合手术或拒绝手术（医学上无法手术）的Ⅰ/Ⅱ期非小细胞肺癌患者进行根治性放疗：一项系统评价
Thorax. 2001 Aug;56(8):628-38. doi: 10.1136/thorax.56.8.628.
6
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial.铂类与非铂类化疗用于晚期非小细胞肺癌：一项随机多中心试验
Lancet. 2001 May 12;357(9267):1478-84. doi: 10.1016/S0140-6736(00)04644-4.
7
Transthoracic needle biopsy of the lung: results of early discharge in 506 outpatients.经胸壁肺穿刺活检：506例门诊患者早期出院结果
Radiology. 2001 Apr;219(1):247-51. doi: 10.1148/radiology.219.1.r01ap11247.
8
Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study.1995年在苏格兰确诊的肺癌患者的管理与生存情况：一项基于全国人口的研究结果
Thorax. 2001 Mar;56(3):212-7. doi: 10.1136/thorax.56.3.212.
9
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies.自1950年以来英国的吸烟、戒烟与肺癌：国家统计数据与两项病例对照研究的结合
BMJ. 2000 Aug 5;321(7257):323-9. doi: 10.1136/bmj.321.7257.323.
10
Epidemiology of lung cancer.肺癌流行病学
Curr Opin Pulm Med. 1998 Jul;4(4):198-204. doi: 10.1097/00063198-199807000-00002.
Zotero 插件